Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Specifications: Purity: 99%+ (HPLC verified) Quantity: 10mg/vial Form: Lyophilized powder Storage: -20C (freezer) COA: Published on our Lab Reports page For laboratory research use only
zero events in both the treatment and placebo group in all trials)
Prescribers assess contraindications such as personal or family history of medullary thyroid carcinoma, pregnancy status, and current medications
These products are supplied solely for use in controlled laboratory settings by qualified professionals
This includes research-grade peptides, which state on the label they're not for pharmaceutical use
Furthermore, in another meta-analysis [23], which excluded ELIXA [24] due to fact that lixisenatide is a short-acting GLP-1RA and all participants had acute coronary syndrome, GLP-1RAs were associated with significant reductions in MACE (HR 0.85, 95% CI 0.800.90), cardiovascular death (HR 0.85, 95% CI 0.780.93), stroke (HR 0.81, 95% CI 0.740.90), and myocardial infarction (HR 0.88, 95% CI 0.810.96) (Table 2)
US$ 24.91
US$ 26.16
US$ 27.22
US$ 28.45
US$ 21.11
US$ 27.69
